Healthpeak Properties, Inc. (DOC) Stock Price & Growth Analysis

Quote Panel

Updated June 18, 2025

1W -2.01 % 1M -3.23 % 3M -15.59 % 1Y -7.08 %

Key Metrics

Market Cap
11.85B
Shares Outstanding
694.73M
Share in Float
691.94M
Dividende
1.21001

Earning Date
24 Jul 2025
Price Target
17.05
Average Volume
6.12M
Beta
1.013

Range
16.64-23.26
Industry
REIT - Healthcare Facilities
Website
https://www.healthpeak.com
Sector
Real Estate

Quote Panel

Updated June 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

9.37x

P/E Ratio

4.23x

P/S Ratio

1.45x

P/B Ratio

1.1

Debt/Equity

10.0%

Net Margin

$0.4

EPS

How DOC compares to sector?

P/E Ratio

Fundamentals

Relative Strength

DOC

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

DOC

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$3B

312%

2026-Revenue

$0.33

445%

2026-EPS

$2B

391%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Deutsche Bank

upgrade

Previous: Not converted

2024-10-21

Now: Buy

Wedbush

upgrade

Previous: Not converted

2024-05-03

Now: Outperform

Exane BNP Paribas

upgrade

Previous: Not converted

2024-04-26

Now: Outperform

Bank of America Securities

upgrade

Previous: Not converted

2024-04-01

Now: Buy

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q2.23

+2%

0.45
vs 0.44

Q3.23

+5%

0.45
vs 0.43

Q4.23

+5%

0.46
vs 0.44

Q1.24

+7%

0.45
vs 0.42

Q2.24

N/A

0.45
vs 0.45

Q3.24

N/A

0.45
vs 0.45

Q4.24

N/A

0.46
vs 0.46

Q1.25

+2%

0.46
vs 0.45

Q2.25

-86%

0.06
vs 0.45

Q3.25

-86%

0.06
vs 0.45

Sales Growth

YoY

Current

Estimates

Q2.23

+2%

135.1M vs 132.2M

Q3.23

+5%

138.5M vs 131.5M

Q4.23

+2%

135.5M vs 132.6M

Q1.24

+352%

606.6M vs 134.3M

Q2.24

+415%

695.5M vs 135.1M

Q3.24

+406%

700.4M vs 138.5M

Q4.24

+415%

698M vs 135.5M

Q1.25

+16%

702.9M vs 606.6M

Q2.25

-1%

689.1M vs 695.5M

Q3.25

-1%

696.7M vs 700.4M

Return on Equity

QoQ

Q2.23

+0%

0
vs -0.02

Q3.23

+0%

0
vs 0

Q4.23

+0%

0
vs 0

Q1.24

+0%

0
vs 0

Q2.24

+2%

0.02
vs 0

Q3.24

+1%

0.01
vs 0.02

Q4.24

+0%

0
vs 0.01

Q1.25

+1%

0.01
vs 0

Institutionnal Ownership

QoQ

Q2.23

355

355
vs 361

-2%

Q3.23

361

361
vs 355

Q4.23

349

349
vs 361

-3%

Q1.24

688

688
vs 349

97%

Q2.24

708

708
vs 688

Q3.24

739

739
vs 708

Q4.24

759

759
vs 739

Q1.25

749

749
vs 759

-1%

Earnings Growth

Forecast

$3B

312%

2026-Revenue

$0.33

445%

2026-EPS

$2B

391%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Deutsche Bank

upgrade

Previous: Not converted

2024-10-21

Now: Buy

Wedbush

upgrade

Previous: Not converted

2024-05-03

Now: Outperform

Exane BNP Paribas

upgrade

Previous: Not converted

2024-04-26

Now: Outperform

Bank of America Securities

upgrade

Previous: Not converted

2024-04-01

Now: Buy

Company Description

17.05USD

9.37x

4.23x

1.45x

1.1

10.0%

$0.4

$3B

$0.33

$2B

Earnings Growth

Latest News

$3B

$0.33

$2B

Company Description

17.05USD

9.37x

4.23x

1.45x

1.1

10.0%

$0.4